Unmet Need for Hepatitis C PCR Testing, New York City, 2009-2010 Emily McGibbon, MPH June 2011 CSTE Annual Conference Hepatitis C (HCV) â the basics Bloodborne virus Main…

Injection Safety: Updates from Michigan and the U.S. Injection Safety: Updates from Michigan and the U.S. October 9, 2015 Emily Goerge, MPH, MSN, RN, CIC 1 Objectives Discuss…

PowerPoint Presentation Peginterferon alfa-2b + RBV versus Interferon alfa-2b RIBAVIC STUDY Phase 3 Treatment Naïve, Chronic HCV and HIV Carrat F, et. al. JAMA. 2004;292:2839-48.…

PowerPoint Presentation PEG alfa-2a + RBV versus PEG alfa-2a versus INF + RBV APRICOT STUDY Phase 3 Treatment Naïve, Chronic HCV and HIV Torriani FJ, et. al. N Engl J…

Slide 1 Hepatitis web study Hepatitis web study Peginterferon alfa-2a + RBV versus Interferon alfa-2a + RBV ACTG 5071 Phase 2 Treatment Naïve, Chronic HCV and HIV Chung…

DAAâs in the treatment of HCV: The Beginning of the end or the end of the beginning for HCV? DAAâs in the treatment of HCV: The Beginning of the end or the end of the beginning…

Slide 1 A NEW SEROLOGICAL SYSTEM FOR PREDICTING HCV TREATMENT RESPONSE, PRELIMINARY RESULTS Tatiana Kuznetsova1, Tatjana Tallo1, Vadim Brjalin2, Irina Reshetnjak1, Maria…